Martilias Farrell, Ph.D. - Publications

Pharmacology University of North Carolina, Chapel Hill, Chapel Hill, NC 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gupta N, Bhatnagar AK. Musculoskeletal manifestations of tuberculosis: An observational study. Journal of Family Medicine and Primary Care. 7: 538-541. PMID 30112304 DOI: 10.4103/jfmpc.jfmpc_7_17  0.64
2016 Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, et al. In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602. PMID 26963248 DOI: 10.1371/journal.pone.0150602  0.6
2015 Huang XP, Karpiak J, Kroeze WK, Zhu H, Chen X, Moy SS, Saddoris KA, Nikolova VD, Farrell MS, Wang S, Mangano TJ, Deshpande DA, Jiang A, Penn RB, Jin J, et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature. PMID 26550826 DOI: 10.1038/nature15699  0.6
2015 Urban DJ, Zhu H, Marcinkiewcz CA, Michaelides M, Oshibuchi H, Rhea D, Aryal DK, Farrell MS, Lowery-Gionta E, Olsen RH, Wetsel WC, Kash TL, Hurd YL, Tecott LH, Roth BL. Elucidation of the Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26383016 DOI: 10.1038/npp.2015.293  0.6
2015 Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O'Donovan MC, Corvin A, Cichon S, Sullivan PF. Evaluating historical candidate genes for schizophrenia. Molecular Psychiatry. 20: 555-62. PMID 25754081 DOI: 10.1038/mp.2015.16  0.6
2015 Crowley JJ, Collins AL, Lee RJ, Nonneman RJ, Farrell MS, Ancalade N, Mugford JW, Agster KL, Nikolova VD, Moy SS, Sullivan PF. Disruption of the microRNA 137 primary transcript results in early embryonic lethality in mice. Biological Psychiatry. 77: e5-7. PMID 25016316 DOI: 10.1016/j.biopsych.2014.05.022  0.6
2014 Bertrand JT, Rech D, Omondi Aduda D, Frade S, Loolpapit M, Machaku MD, Oyango M, Mavhu W, Spyrelis A, Perry L, Farrell M, Castor D, Njeuhmeli E. Systematic Monitoring of Voluntary Medical Male Circumcision Scale-up: adoption of efficiency elements in Kenya, South Africa, Tanzania, and Zimbabwe. Plos One. 9: e82518. PMID 24801374 DOI: 10.1371/journal.pone.0082518  0.01
2013 Farrell MS, Pei Y, Wan Y, Yadav PN, Daigle TL, Urban DJ, Lee HM, Sciaky N, Simmons A, Nonneman RJ, Huang XP, Hufeisen SJ, Guettier JM, Moy SS, Wess J, et al. A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 854-62. PMID 23303063 DOI: 10.1038/npp.2012.251  0.6
2013 Farrell MS, Roth BL. Pharmacosynthetics: Reimagining the pharmacogenetic approach. Brain Research. 1511: 6-20. PMID 23063887 DOI: 10.1016/j.brainres.2012.09.043  0.6
2011 Allen JA, Yadav PN, Setola V, Farrell M, Roth BL. Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo. Translational Psychiatry. 1: e33. PMID 22832607 DOI: 10.1038/tp.2011.35  0.6
2011 Yadav PN, Kroeze WK, Farrell MS, Roth BL. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo. The Journal of Pharmacology and Experimental Therapeutics. 339: 99-105. PMID 21737536 DOI: 10.1124/jpet.111.183780  0.6
2011 Yadav PN, Abbas AI, Farrell MS, Setola V, Sciaky N, Huang XP, Kroeze WK, Crawford LK, Piel DA, Keiser MJ, Irwin JJ, Shoichet BK, Deneris ES, Gingrich J, Beck SG, et al. The presynaptic component of the serotonergic system is required for clozapine's efficacy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 638-51. PMID 21048700 DOI: 10.1038/npp.2010.195  0.6
2010 Dong S, Allen JA, Farrell M, Roth BL. A chemical-genetic approach for precise spatio-temporal control of cellular signaling. Molecular Biosystems. 6: 1376-80. PMID 20532295 DOI: 10.1039/c002568m  0.6
2010 Farrell M, Rosenzweig-Lipson S, Walker E. Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo. Psychopharmacology. 211: 149-59. PMID 20526585 DOI: 10.1007/s00213-010-1893-9  0.6
2010 Abbas AI, Urban DJ, Jensen NH, Farrell MS, Kroeze WK, Mieczkowski P, Wang Z, Roth BL. Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Research. 38: e118. PMID 20185571 DOI: 10.1093/nar/gkq107  0.6
2010 Farrell M, Roth BL. Allosteric antipsychotics: m4 muscarinic potentiators as novel treatments for schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 851-2. PMID 20145632 DOI: 10.1038/npp.2009.206  0.6
2008 Farrell MS, Gilmore K, Raffa RB, Walker EA. Behavioral characterization of serotonergic activation in the flatworm Planaria. Behavioural Pharmacology. 19: 177-82. PMID 18469535 DOI: 10.1097/FBP.0b013e3282fe885e  0.6
Show low-probability matches.